Cargando…
Epilepsy and EEG Phenotype of SLC13A5 Citrate Transporter Disorder
Mutations in the SLC13A5 gene, a sodium citrate cotransporter, cause a rare autosomal recessive epilepsy (EIEE25) that begins during the neonatal period and is associated with motor and cognitive impairment. Patient’s seizure burden, semiology, and electroencephalography (EEG) findings have not been...
Autores principales: | Yang, Qian-Zhou, Spelbrink, Emily M., Nye, Kimberly L., Hsu, Emily R., Porter, Brenda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281881/ https://www.ncbi.nlm.nih.gov/pubmed/32551328 http://dx.doi.org/10.1177/2329048X20931361 |
Ejemplares similares
-
Growth and Overall Health of Patients with SLC13A5 Citrate Transporter Disorder
por: Brown, Tanya L., et al.
Publicado: (2021) -
Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system
por: Spelbrink, Emily M., et al.
Publicado: (2023) -
The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse
por: Fernandez-Fuente, Gonzalo, et al.
Publicado: (2023) -
Plasma Membrane Na(+)-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy
por: Bhutia, Yangzom D., et al.
Publicado: (2017) -
SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy
por: Goodspeed, Kimberly, et al.
Publicado: (2022)